enfortumab vedotin-ejfv for injection
for intravenous use Initial U.S. Approval: 2019

Padcev (enfortumab vedotin-ejfv) is a medication used for the 2nd-line treatment of adults with bladder cancer and cancers of the urinary tract.

Facts about enfortumab vedotin-ejfv for injection

Disease Indications-Urothelial Carcinoma
Manufacturer-Astellas Pharma Inc.
Usage-1.25 mg/kg intravenous infusion
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “sotorasib tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more